TECTONIC THERAPEUTIC, INC. Deferred Tax Assets, Tax Credit Carryforwards, Other
TECTONIC THERAPEUTIC, INC. (TECX) had Deferred Tax Assets, Tax Credit Carryforwards, Other of $25.05 million as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther · last filed 2024-03-14
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Other $25.05M.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Other $16.31M.
- 2021-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Other $0.00.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards, Other |
|---|---|
| 2023-12-31 | $25.05M 10-K · filed 2024-03-14 |
| 2022-12-31 | $16.31M 10-K · filed 2024-03-14 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |